Nothing beats early detection in preventing deaths related to breast cancer, a coalition of patient advocacy groups said, calling for routine mammography in all women aged 40 and older.
HOLX shares reached their highest level since May 2011 yesterday, peaking at $23.22 apiece before closing at $22.36, up 7.0% on the day. Shares were trading at $22.39 as of about 12:50 p.m. today.
The latest published research on mammogram use and breast cancer trends in the U.S. offered mixed messages for women who must navigate betwen the dangers of missing mammograms as well as for getting over-treated as a result of them.
A new study released by the Radiological Society of North America warned that new federal recommendations regarding breast cancer screening could result in skipped mammograms and missed cancers.
Medical imaging analysis devices maker VuCOMP touted FDA premarket approval for its new M-Vu system for helping radiologists detect breast cancer earlier.
The Version 2 M-Vu system’s new indication allows the company to market its devices as an computer-aided detection adjunct to digital mammography.
The FDA approved U-Systems‘ Somo•v breast ultrasound system, the only automated system in the U.S., Canada and 27 European Union countries indicated for use in combination with standard mammography for asymptomatic women with dense breast tissue.
Dense breast tissue, which occurs in nearly half of women, increases the risk of breast cancer up to 4-to-6 times and can also make the cancer more difficult to detect with mammography, some studies have shown.